Skip to Main Content

Author Details

Rafael Delgado
Instituto de Investigacion Hospital 12 de Octubre (imas12)
1988
136
37
PMIDPaper TitleJournal TitlePublished Year
36319593Cross neutralization of SARS-CoV-2 omicron subvariants after repeated doses of COVID-19 mRNA vaccines.J Med Virol2023
37561198Clinical outcomes and antibody transfer in a cohort of infants with in utero or perinatal exposure to SARS-CoV-2 (Coronascope Study).Eur J Pediatr2023
37515137Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2.Viruses2023
37422474Rapid screening of SARS-CoV-2 variants, a key tool for pandemic surveillance.Sci Rep2023
37021830<i>N</i>'-Phenylacetohydrazide Derivatives as Potent Ebola Virus Entry Inhibitors with an Improved Pharmacokinetic Profile.J Med Chem2023
37145391Immune Response Against SARS-CoV-2 Infection and Vaccination in a CD8α-Deficient Patient.J Clin Immunol2023
37040733TLR7 Activation in M-CSF-Dependent Monocyte-Derived Human Macrophages Potentiates Inflammatory Responses and Prompts Neutrophil Recruitment.J Innate Immun2023
36806001Corrigendum to "Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO)".EBioMedicine2023
36571282Transmitted Drug Resistance to Integrase-Based First-Line Human Immunodeficiency Virus Antiretroviral Regimens in Mediterranean Europe.Clin Infect Dis2023
34742581Update and latest advances in antiretroviral therapy.Trends Pharmacol Sci2022
35371043Poxvirus MVA Expressing SARS-CoV-2 S Protein Induces Robust Immunity and Protects Rhesus Macaques From SARS-CoV-2.Front Immunol2022
35563489Topological and Multivalent Effects in Glycofullerene Oligomers as EBOLA Virus Inhibitors.Int J Mol Sci2022
36447613Long-term Evaluation of Residual Viremia in a Clinical Trial of Dolutegravir Plus Lamivudine as Maintenance Treatment for Participants With and Without Prior Lamivudine Resistance.Open Forum Infect Dis2022
36464472First confirmation of importation and transmission in Spain of the newly identified SARS-CoV-2 B.1.1.7 variant.Enferm Infecc Microbiol Clin (Engl Ed)2022
36172368Intranasal administration of a single dose of MVA-based vaccine candidates against COVID-19 induced local and systemic immune responses and protects mice from a lethal SARS-CoV-2 infection.Front Immunol2022
36059485Cellular and humoral immune responses and breakthrough infections after three SARS-CoV-2 mRNA vaccine doses.Front Immunol2022
35921532Potent Neutralizing Activity of Polyclonal Equine Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern.J Infect Dis2022
35154086A Single Dose of an MVA Vaccine Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Protein Neutralizes Variants of Concern and Protects Mice From a Lethal SARS-CoV-2 Infection.Front Immunol2022
35140227Full efficacy and long-term immunogenicity induced by the SARS-CoV-2 vaccine candidate MVA-CoV2-S in mice.NPJ Vaccines2022
34963008Neutralizing Response Against SARS-CoV-2 Variants 8 Months After BNT162b2 Vaccination in Naive and COVID-19-Convalescent Individuals.J Infect Dis2022
35081156New insights into the role of endosomal proteins for African swine fever virus infection.PLoS Pathog2022
33249093Antiviral drugs targeting endosomal membrane proteins inhibit distant animal and human pathogenic viruses.Antiviral Res2021
33685741First confirmation of importation and transmission in Spain of the newly identified SARS-CoV-2 B.1.1.7 variant.Enferm Infecc Microbiol Clin (Engl Ed)2021
33671631Genomic Epidemiology of SARS-CoV-2 in Madrid, Spain, during the First Wave of the Pandemic: Fast Spread and Early Dominance by D614G Variants.Microorganisms2021
33606120Fever without source as the first manifestation of SARS-CoV-2 infection in infants less than 90 days old.Eur J Pediatr2021
33631334Prolonged SARS-CoV-2 cell culture replication in respiratory samples from patients with severe COVID-19.Clin Microbiol Infect2021
34524803Low-Valent Calix[4]arene Glycoconjugates Based on Hydroxamic Acid Bearing Linkers as Potent Inhibitors in a Model of Ebola Virus Cis-Infection and HCMV-gB-Recombinant Glycoprotein Interaction with MDDC Cells by Blocking DC-SIGN.J Med Chem2021
34642637Prime-Boost Vaccination With BNT162b2 Induces High Neutralizing Activity Against SARS-CoV-2 Variants in Naïve and COVID-19-Convalescent Individuals.Open Forum Infect Dis2021
34459889Detection of archived lamivudine-associated resistance mutations in virologically suppressed, lamivudine-experienced HIV-infected adults by different genotyping techniques (GEN-PRO study).J Antimicrob Chemother2021
34598425Comprehensive serological strategy for the diagnosis and monitoring of SARS-CoV-2. From infection to vaccine control.Rev Esp Quimioter2021
34015061DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist.PLoS Pathog2021
34175537Potential pharmacological strategies targeting the Niemann-Pick C1 receptor and Ebola virus glycoprotein interaction.Eur J Med Chem2021
33428961Identification of potential inhibitors of protein-protein interaction useful to fight against Ebola and other highly pathogenic viruses.Antiviral Res2021
32424713Improved blood culture workflow in the time to detection of microorganisms placing incubators systems outside of microbiology laboratory.Braz J Microbiol2020
33253283Seroprevalence analysis of SARS-CoV-2 in pregnant women along the first pandemic outbreak and perinatal outcome.PLoS One2020
33339855Prolonged administration of maraviroc reactivates latent HIV in vivo but it does not prevent antiretroviral-free viral rebound.Sci Rep2020
33070578Recommendations for use of antigenic tests in the diagnosis of acute SARS-CoV-2 infection in the second pandemic wave: attitude in different clinical settings.Rev Esp Quimioter2020
32773658Prevalence and Clinical Manifestations of Congenital Cytomegalovirus Infection in a Screening Program in Madrid (PICCSA Study).Pediatr Infect Dis J2020
32681783Universal screening for SARS-CoV-2 before labor admission during Covid-19 pandemic in Madrid.J Perinat Med2020
32626831HBV-RNA Co-amplification May Influence HBV DNA Viral Load Determination.Hepatol Commun2020
30463889Toxin B PCR Amplification Cycle Threshold Adds Little to Clinical Variables for Predicting Outcomes in <i>Clostridium difficile</i> Infection: a Retrospective Cohort Study.J Clin Microbiol2019
31881030Comparison of the Panther Fusion and Allplex assays for the detection of respiratory viruses in clinical samples.PLoS One2019
31469952Synthesis of Highly Efficient Multivalent Disaccharide/[60]Fullerene Nanoballs for Emergent Viruses.J Am Chem Soc2019
31159598Analytical performance of four molecular platforms used for HIV-1, HBV and HCV viral load determinations.Expert Rev Mol Diagn2019
31074621Correction to Unprecedented Thiacalixarene Fucoclusters as Strong Inhibitors of Ebola cis-Cell Infection and HCMV-gB Glycoprotein/DC-SIGN C-type Lectin Interaction.Bioconjug Chem2019
30926957New filovirus disease classification and nomenclature.Nat Rev Microbiol2019
30912645Unprecedented Thiacalixarene Fucoclusters as Strong Inhibitors of Ebola cis-Cell Infection and HCMV-gB Glycoprotein/DC-SIGN C-type Lectin Interaction.Bioconjug Chem2019
28811244Comparison of the clinical course of Clostridium difficile infection in glutamate dehydrogenase-positive toxin-negative patients diagnosed by PCR to those with a positive toxin test.Clin Microbiol Infect2018
29969601Analysis of drug resistance mutations in whole blood DNA from HIV-1 infected patients by single genome and ultradeep sequencing analysis.J Virol Methods2018
29939289Broad Neutralizing Activity Against Ebolaviruses Lacking the Mucin-Like Domain in Convalescent Plasma Specimens From Patients With Ebola Virus Disease.J Infect Dis2018
  • 1 - 50 of 136

Recommended Authors

Marek Widera
Goethe University Frankfurt, University Hospital, Institute for Medical Virology
Career Start Year 2004
Number of shared co-authors 1
Kayvon Modjarrad
Center for Infectious Diseases Research, Walter Reed Army Institute of Research
Career Start Year 2002
Number of shared co-authors 7
Timothy J Henrich
University of California san francisco
Career Start Year 2002
Number of shared co-authors 2
Satish K Pillai
Vitalant Research Institute, USA University of California san francisco
Career Start Year 2001
Number of shared co-authors 6
Davey M Smith
University of California San Diego
Career Start Year 2001
Number of shared co-authors 4
Sudhir Penugonda
Northwestern University Feinberg School of Medicine
Career Start Year 2000
Number of shared co-authors 2
Matthias Cavassini
Lausanne University Hospital, University of Lausanne
Career Start Year 1999
Number of shared co-authors 6
Carlo Torti
&quotMagna Graecia&quot University
Career Start Year 1998
Number of shared co-authors 6
Viviana Simon
Icahn School of Medicine at Mount Sinai
Career Start Year 1997
Number of shared co-authors 1
Benhur Lee
Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 4
Sharon R Lewin
The University of Melbourne at the Peter Doherty Institute for Infection and Immunity
Career Start Year 1993
Number of shared co-authors 3
Kathleen A Stellrecht
Albany Medical Center Hospitalgrid.413558.e
Career Start Year 1991
Number of shared co-authors 0
Keith R Jerome
Fred Hutchinson Cancer Center
Career Start Year 1991
Number of shared co-authors 1
Steven G Deeks
University of California san francisco
Career Start Year 1988
Number of shared co-authors 9
Pablo Tebas
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1988
Number of shared co-authors 8
Ian Frank
IF School of Medicine, University of Pennsylvania
Career Start Year 1987
Number of shared co-authors 2
Olivier Schwartz
Institut Pasteur, Universite Paris Cite, CNRS UMR9
Career Start Year 1987
Number of shared co-authors 1
Virginia L Kan
VA Medical Center
Career Start Year 1986
Number of shared co-authors 3
Bart L Haagmans
Erasmus Medical Center
Career Start Year 1986
Number of shared co-authors 3
Mohan Somasundaran
University of Massachusetts Chan Medical School
Career Start Year 1985
Number of shared co-authors 0
Stephen Raffanti
Vanderbilt University Medical Center
Career Start Year 1983
Number of shared co-authors 0
Michael S Saag
University of Alabama at Birmingham
Career Start Year 1980
Number of shared co-authors 4
Daniel R Kuritzkes
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1979
Number of shared co-authors 6
Steven M Wolinsky
Northwestern University Feinberg School of Medicine
Career Start Year 1979
Number of shared co-authors 4
Dushyantha Jayaweera
University of Miami, Miller School of Medicine
Career Start Year 1977
Number of shared co-authors 1
Donald S Burke
Graduate School of Public Health, University of Pittsburghgrid.21925.3d
Career Start Year 1976
Number of shared co-authors 2
Robert F Garry
Tulane University School of Medicine
Career Start Year 1974
Number of shared co-authors 24
Ronald Swanstrom
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Career Start Year 1972
Number of shared co-authors 2
Douglas D Richman
Center for AIDS Research, University of California San Diego
Career Start Year 1970
Number of shared co-authors 5
Luis J Montaner
Wistar Institute
Career Start Year 1958
Number of shared co-authors 1

Collaborators

Jos?? R Arribas
La Paz University Hospital
Co-authored papers 15
Bonaventura Clotet
IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol
Co-authored papers 6
Roger Paredes
Hospital Germans Trias i Pujol
Co-authored papers 6
María Colmenares
Co-authored papers 3
Josep M Llibre
Co-authored papers 3
Laura G Barrientos
CNRS, Universite de Strasbourg
Co-authored papers 3
Angela M Gronenborn
University of Pittsburgh
Co-authored papers 2
Henry Kyobe Bosa
Ministry of Health
Co-authored papers 1
Werner Slenczka
Institute of Virology, Philipps University of Marburg
Co-authored papers 1
David M Brett-Major
College of Public Health, University of Nebraska Medical Center
Co-authored papers 1
Laura Evans
University of Washington
Co-authored papers 1
Aneesh K Mehta
Emory University School of Medicine
Co-authored papers 1
Robert A Fowler
Institute of Health Policy
Co-authored papers 1
Susana Hernando
University Hospital Fundacion Alcorcon
Co-authored papers 1
Carolina Nanclares
Co-authored papers 1
Srinivas Murthy
University of British Columbia
Co-authored papers 1
Mark G Kortepeter
College of Allied Health Professions, University of Nebraska Medical Center
Co-authored papers 1
Fran??ois Lamontagne
Universite de Sherbrooke
Co-authored papers 1
Pauline Vetter
University Hospital of Geneva
Co-authored papers 1
Amalio Telenti
Vir Biotechnology Inc.
Co-authored papers 1
Ian Crozier
Christchurch Hospital
Co-authored papers 1
Robert Swanepoel
University of Pretoria
Co-authored papers 1
David A Wohl
The University of North Carolina School of Medicine
Co-authored papers 1
Arne Broch Brantsaeter
Oslo University Hospital
Co-authored papers 1
Christophe Rapp
Begin Military Teaching Hospital
Co-authored papers 1
Moses J Soka
ELWA Hospital
Co-authored papers 1
Timothy H Burgess
Infectious Disease Clinical Research Program, Uniformed Services University
Co-authored papers 1
Miriam Nanyunja
Uganda Virus Research Institute, Ministry of Health
Co-authored papers 1
William A Fischer
University of North Carolina School of Medicine
Co-authored papers 1
Thomas Gr??newald
Hospital Chemnitz
Co-authored papers 1
Release 1.2